Epitranscriptomic m <sup>6</sup> A modifications during reactivation of HIV-1 latency in CD4 <sup>+</sup> T cells
RNA m<sup>6</sup>A modification is important for regulating gene expression and innate immune responses to HIV-1 infection. However, the functional significance of m<sup>6</sup>A modification during HIV-1 latency reactivation is unknown. To address this important question, in this study, we used established cellular models of HIV-1 latency, m<sup>6</sup>A-specific sequencing at single-base resolution, and functional assays. We demonstrate that HIV-1 latency reversal leads to increased levels of cellular m<sup>6</sup>A modification, correlates with cellular m<sup>6</sup>A levels, and is dependent on the catalytic activity of the m<sup>6</sup>A methyltransferase enzyme. We also identified cellular genes that are differentially m<sup>6</sup>A-modified during HIV-1 reactivation, as well as the sites of m<sup>6</sup>A within HIV-1 RNA. Our novel findings point toward a significant role for m<sup>6</sup>A modification in HIV-1 latency reversal.
Authors
- Yutao Zhao (ORCID: https://orcid.org/0000-0002-4496-1394)
- Stacia Phillips (ORCID: https://orcid.org/0000-0002-2801-459X)
- Li Juan Wu (ORCID: https://orcid.org/0000-0002-5468-2487)
- Tarun Mishra (ORCID: https://orcid.org/0000-0002-0968-5654)
- Bethany Wilms
- Chuan He
Institutions
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- University of Chicago (US)
Publication Details
- Journal
- mBio
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1128/mbio.02214-24
- Citations
- 18
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 4.21
Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases